Conclusions: A series of humanized anti-CEA M5A∆CH2 antibodies were designed for immunoPET imaging of colorectal cancer, and the [64Cu]Cu-DO3A-M5A∆CH2-C5 showed high tumor targeting and fast blood clearance supporting its potential for clinical trials. Here, CEACAM5 is linked to neoplasm.